Anthony Sayegh, DO
Family Medicine · Sterling Heights, MINPI 1114961885
Payments from drug & device makers
Across 263 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Amgen$959
- Boehringer Ingelheim$671
- Lilly USA, LLC$371
- GSK$278
- Edwards Lifesciences$138
- plus $1K from 27 others
What the payments were for
- Food & beverage$4,63099%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 67 | $1,052 |
| Amgen(2 entities) | 59 | $959 |
| Boehringer Ingelheim | 26 | $671 |
| Lilly USA, LLC | 25 | $371 |
| GSK | 16 | $278 |
| Edwards Lifesciences | 1 | $138 |
| Pfizer | 5 | $108 |
| AstraZeneca | 8 | $107 |
| Circassia Inc. | 8 | $104 |
| Amarin Pharma, Inc. | 6 | $89 |
| Novartis | 5 | $79 |
| Teva Pharmaceuticals USA, Inc. | 5 | $70 |
| Esperion Therapeutics, Inc. | 3 | $63 |
| Exact Sciences | 3 | $63 |
| Mylan Specialty L.p. | 3 | $54 |
| AbbVie(2 entities) | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Seqirus USA Inc | 2 | $36 |
| Globus Medical | 1 | $29 |
| Abbott | 1 | $27 |
| Boston Scientific | 1 | $26 |
| Procept Biorobotics Corporation | 1 | $25 |
| Covis Pharma GmbH | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Alk-abello, Inc | 1 | $21 |
| Merck | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Medicomp Inc | 1 | $16 |
| Radius Health, Inc. | 1 | $16 |
| Valeritas, Inc. | 1 | $16 |
| Terumo Medical Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,663 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 51 | $58,662 |
| FarxigaDapagliflozin Propanediol | 24 | $29,817 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $29,638 |
| TrulicityDulaglutide | 22 | $25,088 |
| JardianceEmpagliflozin | 15 | $14,576 |
| LinzessLinaclotide | 13 | $7,481 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 21 | $4,637 |
| Atorvastatin Calcium | 332 | $4,249 |
| Ezetimibe | 110 | $2,754 |
| SynthroidLevothyroxine Sodium | 23 | $2,254 |
| Rosuvastatin Calcium | 117 | $2,201 |
| Omega-3 Acid Ethyl Esters | 28 | $2,087 |
| Pravastatin Sodium | 88 | $1,756 |
| Metoprolol Succinate | 64 | $1,670 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $1,656 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,052 | $58,66251 claims |
| GSKTrelegy Ellipta, Shingrix | $278 | $34,27542 claims |
| AstraZenecaFarxiga | $107 | $29,81724 claims |
| Lilly USA, LLCTrulicity | $371 | $25,08822 claims |
| Boehringer IngelheimJardiance | $671 | $14,57615 claims |
| AbbVieLinzess, Synthroid | $53 | $9,73536 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Sterling Heights
- Jeffrey DeitchSterling Heights$220K
- Stuart StollerSterling Heights$141K
- Steven MargolisSterling Heights$91K
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.